Increase in domestic and overseas competition in metabolomics analysis
First written in FY2017. 3 of 6 entries say "Restated". Latest entry: FY2024.
Human Metabolome Technologies moved to the "Worse" side of this theme in 2021, 2 years after the typical company in this theme (2019).
The whole theme swung hardest in 2026: 41 of 85 companies on the "Worse" side.
106 other companies' latest entry also says "Restated".
- FY2024RestatedAnnual report
「Domestic and overseas competition in the contract metabolomics services that form the core of our revenue is increasing, and price competition has also begun to emerge in some areas.」
The company continues to disclose the risks of increasing domestic and overseas competition and price competition. - FY2022WorsenedAnnual report
「The market for contract analysis services other than metabolomics is also expanding, but competition with existing competitors is unavoidable. Whether our Group can secure a certain share of these contract analysis markets will depend on its technological development capabilities and sales proposal capabilities.」
In addition to competition and price competition in the company’s existing contract metabolomics services, competition in contract analysis markets other than metabolomics and the ability to secure market share have been identified as risks. - FY2021WorsenedAnnual report
「Domestic and overseas competition in the contract metabolomics services that form the core of our revenue is increasing, and price competition has also begun to emerge in some areas.」
In addition to the previously disclosed increase in competition, the company identifies the emergence of price competition and competition in other contract analysis services markets. - FY2020RestatedAnnual report
「The number of competitors engaged in metabolome analysis is also increasing, particularly among overseas ventures.」
The company continues to disclose increasing competition in metabolome analysis from overseas ventures, universities and other organizations. - FY2019RestatedAnnual report
「The number of competitors engaged in metabolome analysis is also increasing, particularly among overseas ventures.」
The company continues to disclose increased competition, including overseas ventures and universities accepting paid analytical assignments. - FY2017First statedAnnual report
「The number of competitors engaged in metabolome analysis is also increasing, particularly among overseas ventures. In addition, research bases for metabolome analysis have been established in recent years, mainly at universities, and some have begun accepting paid analytical testing assignments.」
The company identifies increased competition, including overseas ventures and universities accepting paid analytical assignments, as a risk.